Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ASHISH KAMAT and LOUIS L PISTERS.
ASHISH KAMAT
Connection Strength
3.314
LOUIS L PISTERS
  1. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer. 2007 Jul 01; 110(1):62-7.
    View in: PubMed
    Score: 0.300
  2. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol. 2006 Mar; 175(3 Pt 1):881-5.
    View in: PubMed
    Score: 0.273
  3. Metastatic penile cancer in a young Caucasian male: impact of delayed diagnosis. Urol Oncol. 2005 Mar-Apr; 23(2):130-1.
    View in: PubMed
    Score: 0.255
  4. Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure. Urology. 2004 Jun; 63(6):1132-7.
    View in: PubMed
    Score: 0.242
  5. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology. 2004 Jan; 63(1):46-50.
    View in: PubMed
    Score: 0.235
  6. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol. 2003 Nov; 170(5):1868-71.
    View in: PubMed
    Score: 0.233
  7. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urol Oncol. 2016 Feb; 34(2):59.e1-8.
    View in: PubMed
    Score: 0.133
  8. Clinical outcomes of cT1 micropapillary bladder cancer. J Urol. 2015 Apr; 193(4):1129-34.
    View in: PubMed
    Score: 0.124
  9. Management of urethral recurrence after orthotopic urinary diversion. BJU Int. 2010 Jul; 106(1):56-61.
    View in: PubMed
    Score: 0.089
  10. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Cancer. 2009 Mar 15; 115(6):1310-7.
    View in: PubMed
    Score: 0.084
  11. Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology. 2009 Jan; 73(1):147-52.
    View in: PubMed
    Score: 0.082
  12. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008 Jan 01; 26(1):121-6.
    View in: PubMed
    Score: 0.078
  13. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression? Cancer. 2007 Dec 15; 110(12):2700-8.
    View in: PubMed
    Score: 0.077
  14. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol. 2007 Apr; 177(4):1330-4; discussion 1334.
    View in: PubMed
    Score: 0.074
  15. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection. J Urol. 2007 Jan; 177(1):131-8.
    View in: PubMed
    Score: 0.072
  16. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer. Cancer. 2006 Oct 01; 107(7):1483-90.
    View in: PubMed
    Score: 0.071
  17. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. J Urol. 2006 Oct; 176(4 Pt 1):1463-7.
    View in: PubMed
    Score: 0.071
  18. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy. Urology. 2006 Apr; 67(4):769-73.
    View in: PubMed
    Score: 0.069
  19. Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer. J Urol. 2005 Dec; 174(6):2186-90.
    View in: PubMed
    Score: 0.067
  20. Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer? Urology. 2005 Aug; 66(2):327-31.
    View in: PubMed
    Score: 0.066
  21. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate. 2005 Jan 01; 62(1):101-4.
    View in: PubMed
    Score: 0.063
  22. Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer. J Natl Med Assoc. 2004 Jul; 96(7):939-44.
    View in: PubMed
    Score: 0.061
  23. A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. BJU Int. 2024 Sep; 134(3):449-458.
    View in: PubMed
    Score: 0.061
  24. Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy. J Urol. 2003 Nov; 170(5):1856-9.
    View in: PubMed
    Score: 0.058
  25. Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma. BJUI Compass. 2022 Jan; 3(1):37-44.
    View in: PubMed
    Score: 0.050
  26. Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes. Urol Oncol. 2020 04; 38(4):247-254.
    View in: PubMed
    Score: 0.045
  27. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol. 2019 Dec; 37(12):2691-2698.
    View in: PubMed
    Score: 0.042
  28. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer. BJU Int. 2017 05; 119(5):684-691.
    View in: PubMed
    Score: 0.036
  29. Initial experience of teaching robot-assisted radical prostatectomy to surgeons-in-training: can training be evaluated and standardized? BJU Int. 2010 Apr; 105(8):1148-54.
    View in: PubMed
    Score: 0.022
  30. Port-site hernias occurring after the use of bladeless radially expanding trocars. Urology. 2010 Mar; 75(3):574-80.
    View in: PubMed
    Score: 0.022
  31. Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol. 2008 Nov-Dec; 26(6):595-9.
    View in: PubMed
    Score: 0.019
  32. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9.
    View in: PubMed
    Score: 0.019
  33. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int. 2006 Dec; 98(6):1176-80.
    View in: PubMed
    Score: 0.018
  34. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters? Cancer. 2006 Oct 01; 107(7):1503-10.
    View in: PubMed
    Score: 0.018
  35. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer. 2006 Aug 01; 107(3):631-9.
    View in: PubMed
    Score: 0.018
  36. Impact of fellowship training on pathologic outcomes and complication rates of radical prostatectomy. Cancer. 2006 Jul 01; 107(1):54-9.
    View in: PubMed
    Score: 0.017
  37. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Int J Radiat Oncol Biol Phys. 2005 Sep 01; 63(1):134-40.
    View in: PubMed
    Score: 0.017
  38. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):993-1002.
    View in: PubMed
    Score: 0.016
  39. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jan 01; 61(1):14-9.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.